Cite
MLA Citation
Dai Chihara et al.. “Rituximab plus hyper‐CVAD alternating with MTX/Ara‐C in patients with newly diagnosed mantle cell lymphoma: 15‐year follow‐up of a phase II study from the MD Anderson Cancer Center.” British journal of haematology, vol. 172, 2016, pp. 80–88. http://access.bl.uk/ark:/81055/vdc_100028119371.0x00002a